Veracyte Inc
NASDAQ:VCYT

Watchlist Manager
Veracyte Inc Logo
Veracyte Inc
NASDAQ:VCYT
Watchlist
Price: 31.1 USD 0.16% Market Closed
Market Cap: 2.4B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
-55%
Revenue
Forecast
+16%
Operating Income
Forecast
-16%
Net Income
Forecast
+82%

Wall Street
Price Targets

VCYT Price Targets Summary
Veracyte Inc

Wall Street analysts forecast VCYT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VCYT is 46.31 USD with a low forecast of 29.29 USD and a high forecast of 56.7 USD.

VCYT Lowest Forecast
Wall Street Target
29.29 USD
6% Downside
VCYT Average Forecast
Wall Street Target
46.31 USD
49% Upside
VCYT Highest Forecast
Wall Street Target
56.7 USD
82% Upside
Lowest
Price Target
29.29 USD
6% Downside
Average
Price Target
46.31 USD
49% Upside
Highest
Price Target
56.7 USD
82% Upside
Veracyte Inc Competitors:
Price Targets
TGTX
TG Therapeutics Inc
8% Upside
X
688278
Xiamen Amoytop Biotech Co Ltd
27% Upside
4597
Solasia Pharma KK
45% Upside
N
4893
Noile-Immune Biotech Inc
166% Upside
TGTX
TG Therapeutics Inc
8% Upside
X
688278
Xiamen Amoytop Biotech Co Ltd
27% Upside
4597
Solasia Pharma KK
45% Upside
N
4893
Noile-Immune Biotech Inc
166% Upside
CUV
Clinuvel Pharmaceuticals Ltd
126% Upside
NRIX
Nurix Therapeutics Inc
154% Upside
6160
Beigene Ltd
16% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
46% Upside

Revenue
Forecast

Revenue Estimate
Veracyte Inc

For the last 8 years the compound annual growth rate for Veracyte Inc's revenue is 27%. The projected CAGR for the next 3 years is 11%.

27%
Past Growth
11%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Veracyte Inc

The compound annual growth rate of Veracyte Inc's operating income for the next 3 years is 82%.

N/A
Past Growth
82%
Estimated Growth
Estimates Accuracy
-13%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Veracyte Inc

The compound annual growth rate of Veracyte Inc's net income for the next 3 years is 66%.

N/A
Past Growth
66%
Estimated Growth
Estimates Accuracy
-24%
Average Miss
What are analyst estimates?

See Also

Summary
VCYT intrinsic value, competitors valuation, and company profile.
DCF Valuation
VCYT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VCYT stock valuation using valuation multiples.
Wall Street Estimates
VCYT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VCYT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VCYT's stock price target?
Price Target
46.31 USD

According to Wall Street analysts, the average 1-year price target for VCYT is 46.31 USD with a low forecast of 29.29 USD and a high forecast of 56.7 USD.

What is Veracyte Inc's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Veracyte Inc's revenue is 27%. The projected CAGR for the next 3 years is 11%.

What is Veracyte Inc's Operating Income forecast?
Projected CAGR
82%

The compound annual growth rate of Veracyte Inc's operating income for the next 3 years is 82%.

What is Veracyte Inc's Net Income forecast?
Projected CAGR
66%

The compound annual growth rate of Veracyte Inc's net income for the next 3 years is 66%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.